Asia Pacific Ai In Oncology Market Size & Outlook
Asia Pacific ai in oncology market, 2018-2030 (US$M)
Related Markets
Asia Pacific ai in oncology market highlights
- The Asia Pacific ai in oncology market generated a revenue of USD 635.1 million in 2023.
- The market is expected to grow at a CAGR of 33.7% from 2024 to 2030.
- In terms of segment, software solutions was the largest revenue generating component in 2023.
- Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 635.1 million |
| Market revenue in 2030 | USD 4,853.2 million |
| Growth rate | 33.7% (CAGR from 2023 to 2030) |
| Largest segment | Software solutions |
| Fastest growing segment | Software Solutions |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software Solutions, Hardware, Services |
| Key market players worldwide | International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.7% of the global ai in oncology market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,853.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Oncology Market Scope
AI In Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific ai in oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.
Software solutions was the largest segment with a revenue share of 49.6% in 2023. Horizon Databook has segmented the Asia Pacific ai in oncology market based on software solutions, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific (APAC) region is witnessing a rise in the number of cancer cases, driving the demand for advanced technologies such as AI to improve early detection, diagnosis, and personalized treatment. Improvements in healthcare infrastructure and digitalization initiatives are facilitating the smooth integration of AI technologies into oncology practices.
Collaborative initiatives involving technology companies, healthcare providers, and research institutions actively support the development and deployment of AI solutions in the field of oncology. For instance, in June 2022, GE Healthcare collaborated with the National Cancer Centre Singapore (NCCS), which specializes in AI-based cancer care.
Reasons to subscribe to Asia Pacific ai in oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific ai in oncology market databook
-
Our clientele includes a mix of ai in oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific ai in oncology market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific ai in oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific ai in oncology market size, by country, 2018-2030 (US$M)
Asia Pacific AI In Oncology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
